Leukemia Research
Volume 33, Issue 11 , Pages 1475-1480 , November 2009

Phase II trial of temsirolimus in patients with relapsed or refractory multiple myeloma

  • Sherif S. Farag

      Affiliations

    • Departments of Internal Medicine and Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, United States
    • Corresponding Author InformationCorresponding author at: Division of Hematology and Oncology, Department of Internal Medicine, Indiana University School of Medicine, 635 Barnhill Drive, Room 224G, Indianapolis, IN 46202, United States. Tel.: +1 317 278 0460; fax: +1 317 278 2262.
    • ,
  • Shuhong Zhang

      Affiliations

    • Departments of Internal Medicine and Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, United States
    • ,
  • Buffy S. Jansak

      Affiliations

    • Division of Hematology and Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States
    • ,
  • Xiaojing Wang

      Affiliations

    • Departments of Internal Medicine and Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, United States
    • ,
  • Eric Kraut

      Affiliations

    • Division of Hematology and Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States
    • ,
  • Kenneth Chan

      Affiliations

    • College of Pharmacy, The Ohio State University, Columbus, OH, United States
    • ,
  • Janet E. Dancey

      Affiliations

    • National Cancer Institute, Bethesda, MD, United States
    • ,
  • Michael R. Grever

      Affiliations

    • Division of Hematology and Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, United States

Received 17 November 2008 ,Revised 28 January 2009 ,Accepted 30 January 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(09)00060-5

doi: 10.1016/j.leukres.2009.01.039

Leukemia Research
Volume 33, Issue 11 , Pages 1475-1480 , November 2009

Article Tools

* Image Usage & Resolution